Search For "intranasal"
Intranasal herpes infection can produce neurobehavioural symptoms: Study
Updated : 5 months, 1 week ago IST
A study from University of Illinois Chicago researchers finds that herpes infection through the nose can lead to anxiety, motor impairment and cognitive issues.
Read More
Bharat Biotech dispatches first shipments of iNCOVACC across India
Updated : 3 years, 1 month ago IST
The Bharat Biotech on Monday dispatched the first shipments of Worlds first intranasal Covid19 vaccine-- iNCOVACC to various locations across India.
Read More
Bharat Biotech's intranasal heterologous booster dose likely to hit market
Updated : 3 years, 1 month ago IST
According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government of India and State Governments.
Read More
DCGI approves '5-arms intranasal hetrologous booster dose' for restricted
Updated : 3 years, 3 months ago IST
The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is learnt.
Read More
DCGI's subject expert committee to hold discussion on 'Five Arms' intranas
Updated : 3 years, 4 months ago IST
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re
Read More
Bharat Biotech applies for market authorisation from DCGI for five arms in
Updated : 3 years, 6 months ago IST
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
Read More
Bharat Biotech-made iNCOVACC becomes world's first intranasal COVID vaccin
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
Read More
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
Sustain a long and healthy life via new intranasal and injectable gene the
Updated : 3 years, 10 months ago IST
Washington [US], May 14 (ANI): With the elderly population growing globally, it's critical to have an effective and diverse means of mitigating the impact of ageing on human health be it socioeconomically or medically.
Read More
New intranasal and injectable gene therapy could prolong healthy life
Updated : 3 years, 10 months ago IST
Washington [US], May 11 (ANI): As the global elderly population grows, it is socioeconomically and medically critical to have diverse and effective means of mitigating the impact of aging on human health.
Read More
Bharat Biotech's intranasal booster vaccine can be a game-changer if it pr
Updated : 4 years ago IST
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
Read More